H. Amarens Geuzinge - Concepedia

Author

H. Amarens Geuzinge

Erasmus MC ORCID

Also Known As

H Amarens Geuzinge, H Geuzinge, H. Amarens Geuzinge, H.A. Geuzinge, Hiltje A. Geuzinge

Publications

428

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Radboud University Nijmegen The Netherlands Cancer Institute University Medical Center Utrecht Amsterdam University Medical Centers

About

H. Amarens Geuzinge is an author at Erasmus MC specializing in obstetrics, medical imaging, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	168
2	Medicine	1	1	168
3	Obstetrics	1	1	168
4	Medical Imaging	1	1	168
5	Breast Cancer	1	1	168

H. Amarens Geuzinge

Publications

424

Citations

H-Index

Page 1

	Year	Citations
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial Sepideh Saadatmand, H. Amarens Geuzinge, Emiel J. Rutgers, The Lancet Oncology Familial RiskMedical ImagingCancer DetectionCancer ScreeningGynecology	2019	168
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue H. Amarens Geuzinge, Marije F. Bakker, Eveline A.M. Heijnsdijk, JNCI Journal of the National Cancer Institute	2021	82
Breast Cancer Screening Strategies for Women With <i>ATM, CHEK2</i>, and <i>PALB2</i> Pathogenic Variants Kathryn P. Lowry, H. Amarens Geuzinge, Natasha K. Stout, JAMA Oncology	2022	82
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk H. Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J. Rutgers, JAMA Oncology	2020	51
Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk H. Amarens Geuzinge, Eveline A.M. Heijnsdijk, Inge-Marie Obdeijn, The Breast	2021	16
Effects of a leaflet on breast cancer screening knowledge, explicit attitudes, and implicit associations Lindy M. Kregting, Nicolien T. van Ravesteyn, Wolfert Spijker, Patient Education and Counseling	2020	15
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program Hilliene J. van de Schootbrugge‐Vandermeer, Arthur I. Kooyker, Manon C.W. Spaander, Endoscopy	2023	10

Page 1